Specimen Collection Cards Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028, Segmented by Type (Blood, Saliva, Urine, Buccal cells, others), By Material (Cotton & Cellulose-based, Fiber-based, others), by Product (Whatman 903, Ahlstrom 226, FTA, others), by Application (Newborn Screening (NBS), Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Re
Published Date: November - 2024 | Publisher: MIR | No of Pages: 320 | Industry: Healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationSpecimen Collection Cards Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028, Segmented by Type (Blood, Saliva, Urine, Buccal cells, others), By Material (Cotton & Cellulose-based, Fiber-based, others), by Product (Whatman 903, Ahlstrom 226, FTA, others), by Application (Newborn Screening (NBS), Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Re
| Forecast Period | 2024-2028 |
| Market Size (2022) | USD 434.34 million |
| CAGR (2023-2028) | 4.72% |
| Fastest Growing Segment | Blood Sample Segment |
| Largest Market | North America |
Market Overview
Global Specimen Collection Cards Market has valued at USD 434.34 million in 2022 and is anticipated to project steady growth in the forecast period with a CAGR of 4.72% through 2028. Specimen collection cards, also known as filter paper cards or sample collection cards, are specially designed paper or card substrates that are used to collect, transport, and preserve biological samples, such as blood, saliva, urine, and tissue, for various diagnostic testing, research, and screening purposes. These cards offer a convenient and efficient way to collect samples from individuals, especially in remote or resource-limited settings, and ensure their stability during transportation and storage. Specimen collection cards are made from materials with excellent absorption properties. They can absorb and retain biological fluids, allowing a small volume of the sample to be collected and preserved on the card. The materials used in these cards often contain stabilizers that help preserve the integrity of collected samples, including DNA, RNA, proteins, and other biomolecules, during storage and transportation. The increasing need for accurate and early diagnostic testing for various medical conditions, including infectious diseases and chronic illnesses, has driven the demand for efficient specimen collection methods like specimen collection cards. Global health crises like the COVID-19 pandemic highlighted the importance of efficient and safe specimen collection methods. Specimen collection cards were used for remote testing, contact tracing, and surveillance during such outbreaks. The adoption of specimen collection cards for newborn screening programs, where a few drops of blood are collected and stored on cards for various tests, has increased due to their simplicity, efficiency, and minimally invasive nature. Advances in specimen collection card technologies, such as improved materials for preserving samples, enhanced design for better stability during transportation, and integration with automated testing processes, have driven their adoption.
Key Market Drivers
Increasing Use of Newborn Screening Programs
Newborn screening programs are public health initiatives aimed at identifying and diagnosing certain genetic, metabolic, and congenital disorders in newborns shortly after birth. The primary goal of newborn screening is to detect these conditions early, before symptoms manifest, so that appropriate medical interventions and treatments can be initiated promptly. Early detection and intervention can significantly improve the long-term health outcomes of affected infants. Newborn screening aims to identify conditions that, if left untreated, could lead to serious health problems, developmental delays, or even death. By detecting these conditions early, healthcare providers can implement interventions such as dietary changes, medications, or medical treatments that can prevent or mitigate the impact of the disorders. Different countries and regions have variations in their newborn screening panels, but common conditions that are often screened for include phenylketonuria (PKU), congenital hypothyroidism, sickle cell disease, cystic fibrosis, galactosemia, and various metabolic disorders. The specific conditions included in a newborn screening panel depend on factors such as prevalence, found at treatments, and the technology used for testing. Newborn screening typically involves collecting a small blood sample from a newborn's heel shortly after birth, usually within the first 24 to 48 hours of life. This blood sample is usually collected on filter paper or a specimen collection card. The blood is allowed to dry on the card, preserving the samples for subsequent laboratory testing. The dried blood spots collected on the specimen collection cards are sent to specialized laboratories for analysis. These labs use advanced testing methods, such as tandem mass spectrometry and other techniques, to identify abnormal levels of specific substances or markers associated with the screened conditions. Newborn screening tests can sometimes yield false positive results, indicating a potential disorder when the infant is unaffected. To confirm the diagnosis, follow-up testing is conducted, often involving additional blood tests and medical evaluations. Timely follow-up is critical to ensure accurate diagnoses and appropriate interventions. Newborn screening has had a profound impact on public health by reducing morbidity and mortality associated with various congenital and genetic conditions. It has contributed to the early detection of conditions that might otherwise go unnoticed until symptoms become severe. Newborn screening is usually conducted as part of routine medical care, and in many regions, it is mandatory. However, parents are typically informed about the screening process and the conditions being tested for. Some places allow parents to opt out for religious or personal reasons. This factor will accelerate the demand of Global Specimen Collection Cards Market.
Rise in Diagnostic Testing
The rise in diagnostic testing refers to the increasing demand for and utilization of various medical tests and procedures that aid in the identification, diagnosis, and monitoring of diseases, conditions, or health-related parameters in individuals. This trend has been driven by several factors that emphasize the importance of accurate and early detection for effective medical management and improved patient outcomes. Scientific advancements in medical knowledge and technology have led to the development of a wide range of sophisticated diagnostic tests. Techniques such as molecular diagnostics, genetic testing, and advanced imaging modalities allow for earlier and more accurate disease detection. The global aging population is at a higher risk for various chronic diseases and age-related conditions. As a result, there is a growing need for diagnostic tests to identify these health issues in their early stages, enabling timely interventions. Early detection of diseases often leads to more effective treatment outcomes and can prevent the progression of illnesses to more advanced stages. Diagnostic testing plays a crucial role in identifying diseases before symptoms become apparent. The concept of personalized medicine involves tailoring medical decisions and interventions to an individual's genetic makeup, lifestyle, and specific disease characteristics. Diagnostic testing, including genetic testing and biomarker analysis, is essential for guiding personalized treatment approaches. Increased awareness about the importance of regular health check-ups and screening has led more individuals to seek diagnostic tests. As people become more health-conscious, they are more likely to undergo testing for early disease detection. Healthcare providers are increasingly recognizing the value of preventive care and early disease detection. They may recommend routine screening tests based on guidelines and patients' risk factors. Global health events, such as pandemics like COVID-19, highlight the importance of diagnostic testing for identifying and containing infectious diseases. Testing is a critical tool for disease surveillance, contact tracing, and managing outbreaks. This factor will pace up the demand of Global Specimen Collection Cards Market.
Technological Advancements
Technological advancements in specimen collection cards have played a significant role in improving the efficiency, accuracy, and convenience of collecting, transporting, and preserving biological samples for diagnostic testing and research. Advancements in material science have led to the development of specialized filter paper and card substrates with improved absorption properties. These materials can efficiently absorb and retain various biological fluids, such as blood, saliva, urine, and tissue samples, while maintaining sample integrity. Incorporation of preservation stabilizers within the specimen collection cards can help maintain the stability of collected samples over longer periods. These stabilizers prevent degradation of biomolecules, such as DNA and RNA, during storage and transportation, ensuring accurate test results. Some specimen collection cards are equipped with integrated barcodes or QR codes that uniquely identify each sample. This technology streamlines the sample tracking process, reduces the risk of sample mix-ups, and enhances data accuracy. Technological advancements have enabled specimen collection cards to be seamlessly integrated into automated laboratory workflows. This integration reduces manual handling, improves sample tracking, and enhances overall testing efficiency. Microfluidic technologies have been applied to specimen collection cards, allowing for precise partitioning of samples into multiple segments. This is particularly useful for conducting multiple tests on a single sample. Advanced drying techniques and chemical treatments have been developed to better preserve samples on specimen collection cards. These methods help prevent contamination and degradation of samples during storage. Some specimen collection cards are designed to facilitate multiplex testing, which allows for the simultaneous analysis of multiple analytes (e.g., proteins, nucleic acids) from a single sample. This technology enhances efficiency in diagnostic and research settings. Advancements in specimen collection card technology have led to the development of point-of-care testing solutions. These cards enable rapid and accurate testing in decentralized healthcare settings, such as clinics and remote areas. Technological advancements have allowed for the customization of specimen collection card designs to suit specific testing requirements. This includes variations in size, shape, absorption capacity, and features for specific sample types. Advancements in environmentally friendly materials and production processes have led to the development of more sustainable specimen collection cards, reducing the overall ecological impact of their use. This factor will help in the development of the Global Specimen Collection Cards Market.
Download Free Sample Report
Key Market Challenges
Compatibility with Tests and Technologies
The ability of specimen collection cards to effectively preserve and deliver high-quality samples is crucial for accurate diagnostic testing and research. However, different tests and technologies have unique requirements and sensitivities that need to be considered. Different diagnostic tests require specific sample formats, volumes, and conditions. For example, molecular tests (e.g., PCR, sequencing) have specific requirements for DNA and RNA preservation, while immunoassays might require intact protein preservation. Certain tests require a minimum sample volume to yield accurate results. If the specimen collection cards cannot provide sufficient sample volume, it can lead to inadequate testing outcomes. Specimen collection cards must be compatible with various assay platforms and testing instruments used in laboratories. This includes ensuring that the samples can be easily extracted and processed for testing. Specimen collection cards are used for a variety of sample types, such as blood, saliva, urine, and tissue. Ensuring compatibility with all these sample types and the specific tests conducted on them can be challenging. Some diagnostic assays involve complex procedures or multiplexing, where multiple targets are tested simultaneously. Specimen collection cards need to be able to accommodate such complexity. Some diagnostic assays involve complex procedures or multiplexing, where multiple targets are tested simultaneously. Specimen collection cards need to be able to accommodate such complexity.
Sample Integrity and Stability
The quality of collected samples is crucial for accurate and reliable diagnostic testing and research. Various factors can affect the integrity and stability of samples stored on specimen collection cards. Changes in temperature, humidity, and exposure to light can adversely affect the stability of samples. Extreme conditions during storage and transportation can lead to sample degradation and compromised test results. Different sample types (e.g., blood, saliva, urine) have varying stability profiles. The volume of the sample collected can also influence how well it is preserved on the collection card. If there is a delay in transporting the specimen collection cards to the laboratory, the samples might degrade, potentially leading to inaccurate results. The design of the collection card, including the material used and the absorption properties, can impact how well samples are preserved. Poorly designed cards might not effectively preserve samples or might allow contamination. The absence of standardized protocols for collecting, handling, storing, and transporting samples can lead to inconsistencies in sample preservation, compromising the reliability of test results. Improper handling of specimen collection cards, such as folding, stacking, or mishandling during transportation, can damage the samples and impact their integrity. DNA, RNA, and other biomolecules are susceptible to degradation over time. Without proper preservation methods, samples can lose their molecular integrity, affecting downstream molecular testing. In some cases, there might be a lack of adequate quality control measures during the manufacturing of specimen collection cards, which can impact their performance in preserving samples.
Key Market Trends
Integration with Lab Automation
Lab automation involves the use of technology and robotics to streamline and enhance various laboratory processes, including sample handling, testing, analysis, and data management. Integrating specimen collection cards with lab automation systems offers several benefits that improve efficiency, accuracy, and overall laboratory workflow.
Segmental Insights
Type Insights
In 2022, the Global Specimen Collection Cards Market was dominated by the blood sample segment with overall revenue of 89.88% in 2022 and is predicted to continue expanding over the coming years.
Material Insights
In 2022, the Global Specimen Collection Cards Market was dominated by cotton & cellulose-based material with a share of around 55.98% in 2022 and is predicted to continue expanding over the coming years.
Product Insights
In 2022, the Global Specimen Collection Cards Market was dominated by Whatman 903 product segment with a share of around 41.86% in 2022 and is predicted to continue expanding over the coming years.
Distribution Channel Insights
In 2022, the Global Specimen Collection Cards Market was dominated by offline distribution channel segment with a share of around 70.25% in 2022 and is predicted to continue expanding over the coming years.
Application Insights
In 2022, the Global Specimen Collection Cards Market was dominated by newborn screening segment with a share of around 25.25% in 2022 and is predicted to continue expanding over the coming years.
End-user Insights
In 2022, the Global Specimen Collection Cards Market was dominated by hospitals & clinics end-use segment with a share of around 74.94% in 2022 and is predicted to continue expanding over the coming years.
Download Free Sample Report
Regional Insights
The North America region has established itself as the leader in the Global Specimen Collection Cards Market with a share of around 41.55% in 2022.
Recent Developments
- In February 2023, Capitainer AB has unveiled a cutting-edge self-sampling solution that can collect five times the amount of blood as its previous one. This advancement enables for a greater variety of analyses and testing procedures. Furthermore, the new product is designed to be easier to use, thus simplifying the implementation of the solution for laboratories. The improved features of the new product have the potential to transform the way blood samples are collected and analysed, providing improved efficiency and flexibility in the field of diagnostic and research.
- In February 2023, The North Carolina Department of health and human services has announced an updated requirement for newborns to be screened for two additional diseases. In accordance with the health department's new mandate, newborns will be required to be screened for the following
- In July 2023, Rhinostics has unveiled the innovative VERIstic collection device, which revolutionizes the small volume blood collection process. The VERIstic collection system combines the traditional method of collecting capillary blood with an automated cap, simplifying the collection process, and providing significant advantages in terms of time, cost, and workflow effectiveness in laboratories. The collection process is now faster, simpler, and more comfortable for both patients and clinicians, improving the overall patient experience and allowing for a simplified, hands-free sample collection and analysis workflow.
- In May 2022, the strategic partnership between Abson Diagnostics, a diagnostics company, and BD, a medical diagnostics company, has been deepened to lead innovation in the field of blood sample collection with a particular emphasis on exploring novel care settings. This expanded partnership is intended to provide patients with the ability to collect blood samples for diagnostic testing at home, thereby increasing the accessibility and convenience of healthcare services to the patient. This advancement is expected to transform the way diagnostic testing is carried out, bringing the advantages of home blood sample collection for both the patient and healthcare provider.
Key Market Players
·
·
·
·
·
·
·
·
·
·
| By Type | By Material | By Product | By Application | By Distribution Channel | By End User | By Region |
|
|
|
|
|
|
|
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy